메뉴 건너뛰기




Volumn 30, Issue 10, 2009, Pages 972-976

Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TOBRAMYCIN;

EID: 70350029293     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/605922     Document Type: Article
Times cited : (351)

References (21)
  • 1
    • 70350019843 scopus 로고    scopus 로고
    • Carbapenem-resistant Klebsiella pneumoniae outbreak in southern Israel: From crisis to ongoing control
    • In: Program and abstracts of the (Washington, DC). Washington, DC: American Society for Microbiology; and Alexandria, VA: Infectious Diseases Society of America
    • Borer A, Eskira S, Nativ R, et al. Carbapenem-resistant Klebsiella pneumoniae outbreak in southern Israel: from crisis to ongoing control. In: Program and abstracts of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America 46th Annual Meeting (Washington, DC). Washington, DC: American Society for Microbiology; and Alexandria, VA: Infectious Diseases Society of America, 2008.
    • (2008) 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America 46th Annual Meeting
    • Borer, A.1    Eskira, S.2    Nativ, R.3
  • 2
    • 40549126250 scopus 로고    scopus 로고
    • Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
    • Schwaber M, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028-1033.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 1028-1033
    • Schwaber, M.1    Klarfeld-Lidji, S.2    Navon-Venezia, S.3    Schwartz, D.4    Leavitt, A.5    Carmeli, Y.6
  • 3
    • 35948993007 scopus 로고    scopus 로고
    • Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel
    • Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007; 30:525-529.
    • (2007) Int J Antimicrob Agents , vol.30 , pp. 525-529
    • Samra, Z.1    Ofir, O.2    Lishtzinsky, Y.3    Madar-Shapiro, L.4    Bishara, J.5
  • 4
    • 62949166438 scopus 로고    scopus 로고
    • Metallo-ß-lactamases in gram-negative bacteria: Introducing the era of pan-resistance?
    • Maltezou HC. Metallo-b-lactamases in gram-negative bacteria: introducing the era of pan-resistance? Int J Antimicrob Agents 2008; 33:405.e1-405.e7.
    • (2008) Int J Antimicrob Agents , vol.33
    • Maltezou, H.C.1
  • 5
    • 40449136746 scopus 로고    scopus 로고
    • Appropriate vs. inappropriate antimicrobial therapy
    • Davey PG, Marwick C. Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect 2008; 14(Suppl 3):15-21.
    • (2008) Clin Microbiol Infect , vol.14 , Issue.SUPPL 3 , pp. 15-21
    • Davey, P.G.1    Marwick, C.2
  • 6
    • 56749155916 scopus 로고    scopus 로고
    • Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and impact of antimicrobial and adjunctive therapies
    • Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee P. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-1106.
    • (2008) Infect Control Hosp Epidemiol , vol.29 , pp. 1099-1106
    • Patel, G.1    Huprikar, S.2    Factor, S.H.3    Jenkins, S.G.4    Calfee, P.5
  • 7
    • 35448951860 scopus 로고    scopus 로고
    • Risk factors of carbapenemresistant Klebsiella pneumoniae infections: A matched case-control study
    • Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenemresistant Klebsiella pneumoniae infections: a matched case-control study. J Antimicrob Chemother 2007; 60:1124-1130.
    • (2007) J Antimicrob Chemother , vol.60 , pp. 1124-1130
    • Falagas, M.E.1    Rafailidis, P.I.2    Kofteridis, D.3
  • 8
    • 0028241340 scopus 로고
    • Nosocomial bloodstream infection in critically ill patients
    • Excess length of stay, extra costs, and attributable mortality
    • Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-1601.
    • (1994) JAMA , vol.271 , pp. 1598-1601
    • Pittet, D.1    Tarara, D.2    Wenzel, R.P.3
  • 9
    • 0030459510 scopus 로고    scopus 로고
    • Vancomycin- resistant enterococcal bacteremia: Natural history and attributable mortality
    • Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin- resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23:1234-1239.
    • (1996) Clin Infect Dis , vol.23 , pp. 1234-1239
    • Edmond, M.B.1    Ober, J.F.2    Dawson, J.D.3    Weinbaum, D.L.4    Wenzel, R.P.5
  • 10
    • 37549020378 scopus 로고    scopus 로고
    • Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock
    • Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
    • (2008) Crit Care Med , Issue.36 , pp. 296-327
    • Dellinger, R.P.1    Levy, M.M.2    Carlet, J.M.3
  • 11
    • 0013902668 scopus 로고
    • Antibiotic susceptibility testing by a standardized single disk method
    • Bauer AW, Kirby WMM,Sherris JC, Turk M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45:493-496.
    • (1966) Am J Clin Pathol , vol.45 , pp. 493-496
    • Bauer, A.W.1    Kirby, W.M.M.2    Sherris, J.C.3    Turk, M.4
  • 12
    • 34548070507 scopus 로고    scopus 로고
    • Evaluation of methods to identify the Klebsiella pneumoniae carbapenase in enterobactereaceae
    • Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenase in enterobactereaceae. J Clin Microbiol 2007; 45:2723-2725.
    • (2007) J Clin Microbiol , vol.45 , pp. 2723-2725
    • Anderson, K.F.1    Lonsway, D.R.2    Rasheed, J.K.3
  • 13
    • 70350027816 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Approved standard; CLSI document. Wayne, PA: CLSI
    • CLSI. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Approved standard; CLSI document. Wayne, PA: CLSI, 2006; M100-S16.
    • (2006) CLSI
  • 14
    • 0028893025 scopus 로고
    • The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study
    • Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273:117-123.
    • (1995) JAMA , vol.273 , pp. 117-123
    • Rangel-Frausto, M.S.1    Pittet, D.2    Costigan, M.3    Hwang, T.4    Davis, C.S.5    Wenzel, R.P.6
  • 15
    • 0242659142 scopus 로고    scopus 로고
    • Attributable mortality of nosocomial candidemia, revisited
    • Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37:1172-1177.
    • (2003) Clin Infect Dis , vol.37 , pp. 1172-1177
    • Gudlaugsson, O.1    Gillespie, S.2    Lee, K.3
  • 16
    • 0141869007 scopus 로고    scopus 로고
    • Outcomes associated with vancomycin-resistant enterococci: A meta-analysis
    • Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003; 24:690-698.
    • (2003) Infect Control Hosp Epidemiol , vol.24 , pp. 690-698
    • Salgado, C.D.1    Farr, B.M.2
  • 18
    • 0029070855 scopus 로고
    • Attributable mortality of bacteremia associated with the Bacteroides fragilis group
    • Redondo CM, Arbo MDJ, Grindlinger J, Snydman DR. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin Infect Dis 1995; 20:1492-1496.
    • (1995) Clin Infect Dis , vol.20 , pp. 1492-1496
    • Redondo, C.M.1    Arbo, M.D.J.2    Grindlinger, J.3    Snydman, D.R.4
  • 19
    • 0024581812 scopus 로고
    • Coagulase-negative staphylococcal bacteremia, mortality and hospital stay
    • Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia, mortality and hospital stay. Ann Intern Med 1989; 110:9-16.
    • (1989) Ann Intern Med , vol.110 , pp. 9-16
    • Martin, M.A.1    Pfaller, M.A.2    Wenzel, R.P.3
  • 20
    • 39149100281 scopus 로고    scopus 로고
    • Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 blactamase- producing Klebsiella pneumoniae epidemic clone.
    • Cobo J, Morosini MI, Pintado V, et al. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 blactamase- producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis 2008; 60:319-322.
    • (2008) Diagn Microbiol Infect Dis , vol.60 , pp. 319-322
    • Cobo, J.1    Morosini, M.I.2    Pintado, V.3
  • 21
    • 23044515861 scopus 로고    scopus 로고
    • Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
    • Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005; 49: 3136-3146.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 3136-3146
    • Kasiakou, S.K.1    Michalopoulos, A.2    Soteriades, E.S.3    Samonis, G.4    Sermaides, G.J.5    Falagas, M.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.